Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Return on Equity (2022 - 2025)

Historic Return on Equity for Cardio Diagnostics Holdings (CDIO) over the last 4 years, with Q3 2025 value amounting to 0.73%.

  • Cardio Diagnostics Holdings' Return on Equity rose 17100.0% to 0.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.73%, marking a year-over-year increase of 17100.0%. This contributed to the annual value of 1.34% for FY2024, which is 9700.0% up from last year.
  • As of Q3 2025, Cardio Diagnostics Holdings' Return on Equity stood at 0.73%, which was up 17100.0% from 0.59% recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Return on Equity ranged from a high of 0.24% in Q2 2022 and a low of 3.84% during Q1 2024
  • For the 4-year period, Cardio Diagnostics Holdings' Return on Equity averaged around 1.66%, with its median value being 1.27% (2024).
  • As far as peak fluctuations go, Cardio Diagnostics Holdings' Return on Equity plummeted by -33500bps in 2023, and later soared by 32800bps in 2025.
  • Cardio Diagnostics Holdings' Return on Equity (Quarter) stood at 0.67% in 2022, then crashed by -375bps to 3.19% in 2023, then skyrocketed by 60bps to 1.27% in 2024, then surged by 42bps to 0.73% in 2025.
  • Its Return on Equity stands at 0.73% for Q3 2025, versus 0.59% for Q2 2025 and 0.56% for Q1 2025.